Belen Pascual, PhD

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Frontotemporal Dementia 74%
3. (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine 62%
4. Frontotemporal Lobar Degeneration 50%
5. Brain 49%
6. Dementia 42%
7. Amyloid 39%
8. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 39%
9. Positron-Emission Tomography 37%
10. Neuroimaging 36%
11. Smartphone 32%
12. Lynx 31%
13. Magnetic Resonance Imaging 28%
14. Cognitive Dysfunction 26%
15. Mobile Applications 24%
16. Primary Progressive Aphasia 22%
17. Biomarkers 22%
18. Clinical Trials 21%
19. Autosomal recessive Spastic paraplegia 11 19%
20. Intermediate Filaments 19%
21. Inflammation 19%
22. Vascular Dementia 18%
23. Regulatory T-Lymphocytes 17%
24. Parkinson Disease 17%
25. Ear 17%
26. Corpus Callosum 15%
27. Language 15%
28. Mutation 15%
29. Apathy 15%
30. Muscarinic M4 Receptors 15%
31. Primary Progressive Nonfluent Aphasia 14%
32. Carbon-11 14%
33. Agraphia 13%
34. Psycholinguistics 13%
35. Spastic Paraparesis 13%
36. Hereditary Spastic Paraplegia 13%
37. levodopa drug combination carbidopa 13%
38. Specific Language Disorder 12%
39. Amyotrophic Lateral Sclerosis 12%
40. Neurodegenerative Diseases 12%
41. Light 12%
42. Memory 12%
43. Disorders of Excessive Somnolence 12%
44. Psychology Recognition 12%
45. Proteins 12%
46. Chromosomes, Human, Pair 15 12%
47. Atrophy 12%
48. Flumazenil 12%
49. Essential Tremor 12%
50. Linguistics 11%